Such a treatment also may help determine how many people were exposed. With a limited supply of COVID-19 tests in the United States, people with mild symptoms are less likely to be tested, leaving ...
Autoantibody assays may have significant differences due to the heterogeneity of autoantibodies, including epitope specificity, isotype, and affinity/avidity. This makes it challenging for clinical ...
In the scurry to track, isolate and otherwise beat back the global coronavirus pandemic, testing people for traces of SARS-CoV-2, the virus that causes COVID-19, is a high priority. But a different ...
The Food and Drug Administration (FDA) granted Assure Tech emergency use authorization for a point-of-care test capable of detecting past COVID-19 infections through blood samples. In July, the Assure ...
Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19. Rebecca DuBois, associate professor of ...
With COVID-19 case rates on the rise and the delta variant's highly contagious nature, doctors say people across California are increasingly curious about COVID tests. Doctor Nam Tran is the senior ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced performance validation and the upcoming launch ...
The 'game changer' that wasn't: Company falsely claimed FDA authorization for coronavirus blood test
The company claimed it would distribute the first coronavirus antibody test authorized by the US Food and Drug Administration. It promised to detect current and past infections in as little as two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback